Jan 16, 2020 / 12:30AM GMT
Tejas Rajeev Savant - JP Morgan Chase & Co, Research Division - Analyst
Good afternoon, everyone. Thanks for staying until the end on Wednesday. It's my -- my name is Tejas Savant, and I work with Tycho on the life sciences team at JPMorgan. It's my pleasure this afternoon to introduce Eric Green, CEO of West Pharmaceuticals. At the end of Eric's presentation, there will be a management breakout in the Borgia Room, which is right outside.
With that, I'd like to hand it over to Eric.
Eric M. Green - West Pharmaceutical Services, Inc. - CEO, President & Director
Great. Tejas, thank you. And thank you for the invitation to participate this year at the JPMorgan Healthcare Conference. Great series of conversations all day today.
Before I get started, I just want to remind you about our safe harbor statement that's here posted on this PowerPoint presentation. But also, you can find our safe harbor statement in our website at westpharma.com.
Let me tell you a little bit about West and the story of West. We are -- our focus is around
West Pharmaceutical Services Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
